EFG Asset Management (Americas)’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,065
Closed -$201K 137
2024
Q1
$201K Sell
9,065
-3,273
-27% -$79.8K 0.06% 126
2023
Q4
$339K Sell
12,338
-1,375
-10% -$33.2K 0.07% 121
2023
Q3
$306K Sell
13,713
-624
-4% -$16K 0.07% 126
2023
Q2
$365K Sell
14,337
-624
-4% -$15.1K 0.08% 123
2023
Q1
$334K Buy
14,961
+659
+5% +$15.9K 0.08% 120
2022
Q4
$339K Sell
14,302
-852
-6% -$19.8K 0.08% 111
2022
Q3
$252K Buy
15,154
+872
+6% +$19.6K 0.06% 125
2022
Q2
$284K Sell
14,282
-1,496
-9% -$30.2K 0.07% 119
2022
Q1
$435K Buy
15,778
+1,540
+11% +$44K 0.08% 118
2021
Q4
$587K Buy
14,238
+902
+7% +$39.8K 0.1% 111
2021
Q3
$619K Buy
13,336
+2,124
+19% +$92.7K 0.11% 107
2021
Q2
$448K Buy
11,212
+3,533
+46% +$151K 0.08% 117
2021
Q1
$413K Buy
7,679
+1,867
+32% +$108K 0.08% 116
2020
Q4
$284K Sell
5,812
-1,043
-15% -$48.3K 0.06% 123
2020
Q3
$223K Buy
+6,855
New +$218K 0.05% 132

Other funds holding VCYT

EFG Asset Management (Americas)'s VCYT Position: Q2 2024 in Review

EFG Asset Management (Americas) sold out of Veracyte (VCYT) in Q2 2024, closing a stake of 9,065 shares — an estimated $201K sold.

EFG Asset Management (Americas) first reported a position in VCYT in Q3 2020 and held it in 15 quarters. The position peaked at $619K in Q3 2021. 240 funds tracked by Wall St. Rank hold VCYT as of Q2 2024.

  • EFG Asset Management (Americas) reported no remaining Veracyte position as of Q2 2024 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 9,065 Veracyte shares in Q2 2024, an estimated $201K.
  • EFG Asset Management (Americas) first reported a position in Veracyte in Q3 2020 and held it in 15 quarters.
  • EFG Asset Management (Americas)'s Veracyte position peaked at $619K in Q3 2021.
  • 240 funds tracked by Wall St. Rank held Veracyte as of Q2 2024.

Based on EFG Asset Management (Americas)'s 13F filing for Q2 2024, filed 6 Aug 2024.